[Patent foramen ovale and migraine, a fortuitus association or a causal relationship?]

J Schoenen1, Ph Burette, P Materne

  • 1Unité de Recherches sur les Céphalées, Service de Neurologie, CHR Citadelle, Liège, Belgique. jschoenen@ulg.ac.be

Revue Medicale De Liege
|August 17, 2006
PubMed

Insights

Migraine with aura is linked to patent foramen ovale (PFO). While PFO closure may reduce migraine frequency, definitive evidence from controlled trials is pending, so it is not currently recommended for migraine treatment.

Area of Science:

  • Neurology
  • Cardiology
  • Genetics

Background:

  • Migraine with aura (MWA) frequently co-occurs with patent foramen ovale (PFO).
  • MWA is a risk factor for ischemic stroke in individuals under 55, with PFO implicated in some cases.
  • The etiological relationship between PFO and MWA remains unclear, with possibilities including causal links or shared genetic factors.

Observation:

  • Cortical spreading depression, the mechanism behind migrainous aura, might be facilitated by a PFO.
  • Retrospective, uncontrolled studies indicate that percutaneous PFO closure, performed for stroke or decompression illness, may decrease migraine attack frequency.
  • These observed benefits include reductions in migraines with and without aura.

Findings:

  • Evidence suggests a potential link between PFO and migraine, with some studies showing reduced migraine frequency after PFO closure.
  • The precise role of PFO in migraine pathophysiology requires further investigation.
  • Current data is largely from uncontrolled studies, necessitating more rigorous research.

Implications:

  • Prospective, controlled trials are underway to definitively assess the efficacy of PFO closure for migraine management.
  • Until trial results are available, there is no established rationale for recommending PFO closure specifically for treating migraine.
  • Further research will clarify the therapeutic potential of PFO intervention in patients with migraine and PFO.

Related Concept Videos

Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Mitral Valve Prolapse I: Introduction01:27

Mitral Valve Prolapse I: Introduction

IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
The Arch of Aorta01:10

The Arch of Aorta

The coronary arteries, originating from the ascending aorta, bifurcate from two sinuses located within the ascending aorta. Positioned just above the aortic semilunar valve, these sinuses house essential aortic baroreceptors and chemoreceptors, crucial for maintaining cardiac function. The left coronary artery and the right coronary artery branch off from the left posterior and anterior aortic sinuses, respectively.
Encircling the heart, the coronary arteries form a ring-like structure before...